Publicaciones en colaboración con investigadores/as de NavarraBiomed (3)

2024

  1. Mineralocorticoid receptor (MR) antagonist eplerenone and MR modulator balcinrenone prevent renal extracellular matrix remodeling and inflammation via the MR/proteoglycan/TLR4 pathway

    Clinical science (London, England : 1979), Vol. 138, Núm. 16, pp. 1025-1038

2022

  1. Biglycan Is a Novel Mineralocorticoid Receptor Target Involved in Aldosterone/Salt-Induced Glomerular Injury

    International Journal of Molecular Sciences, Vol. 23, Núm. 12

  2. Mineralocorticoid Receptor Antagonism Prevents the Synergistic Effect of Metabolic Challenge and Chronic Kidney Disease on Renal Fibrosis and Inflammation in Mice

    Frontiers in Physiology, Vol. 13